Lead Product(s) : Yttrium Radioisotopes
Therapeutic Area : Oncology
Study Phase : Approved
Sponsor : Grand Pharmaceutical Group Limited
Deal Size : Not Applicable
Deal Type : Not Applicable
Details : SIR-Spheres Y-90 resin microspheres is the first therapeutic radiopharmaceutical approved by the NMPA based on clinical trial data, for the treatment of patients with colorectal cancer liver metastases.
Brand Name : SIR-Spheres Y-90
Molecule Type : Large molecule
Upfront Cash : Not Applicable
February 09, 2022
Lead Product(s) : Yttrium Radioisotopes
Therapeutic Area : Oncology
Highest Development Status : Approved
Sponsor : Grand Pharmaceutical Group Limited
Deal Size : Not Applicable
Deal Type : Not Applicable
LOOKING FOR A SUPPLIER?